Kevin美股成长价投2019-12-31 06:31
$Orgenesis(ORGS)$ $BioLife Solutions(BLFS)$ 近几年美国细胞治疗和再生医学领域发展迅速,投入资本年增长速度超过20%,Orgs为其它公司提供研发服务。算是这波细胞治疗和再生医学淘金热潮里卖铲子的商家。所以近几年公司录的非常稳定而高速的营收增长。股价从高位大幅调整下来,已经开始修复,目...查看全文
牛唐2019-10-11 22:12
$BioLife Solutions(BLFS)$ 全部收购了SAVSU,受益于细胞疗法的火热,2019年收入指引是增长39%,毛利率是七成左右,目前股价回调的厉害,可以关注查看全文
$BioLife Solutions(BLFS)$ 内部交易: 2021-05-17,Exec VP & Chief Scientific Off,Mathew Aby J. ,期权,10000普通股, $1.64
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-012837 Size: 14 KB 网页链接
$BioLife Solutions(BLFS)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001437749-21-012805 Act: 33 Size: 72 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-05-13,Chief Marketing Officer,Berard Todd ,卖出,6160普通股, $29.52
$BioLife Solutions(BLFS)$ 内部交易: 2021-05-14,Chief Marketing Officer,Berard Todd ,卖出,6160普通股, $29.68
$BioLife Solutions(BLFS)$ 内部交易: 2021-05-14,Chief Marketing Officer,Berard Todd ,期权,6160普通股, $1.64
$BioLife Solutions(BLFS)$ 内部交易: 2021-05-13,Chief Marketing Officer,Berard Todd ,期权,6160普通股, $1.64
$BioLife Solutions(BLFS)$ 内部交易: 2021-05-17,Director,Hinson Andrew G ,卖出,2500普通股, $29.06
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-012571 Size: 14 KB 网页链接
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-012572 Size: 4 KB 网页链接